CS logo
small CS logo
Orlando Heart Center

Orlando, Florida, United States
Heart hospital in Orlando, Florida
1222 S Orange Ave 1st Floor, Orlando, FL 32806

About Orlando Heart Center


"We're verbally screening visitors at our hospitals & cancer center. Don't visit if you have: Fever 100.4F+ Cough OR shortness of breath Recent case of pneumonia OR flu within 14 days Traveled internationally OR by cruise ship Had contact with a confirmed or investigatory case."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Abbott Medical Devices
3
Biotronik, Inc.
2
Boston Scientific Corporation
2
Gilead Sciences
2
United Therapeutics
2
ARYx Therapeutics
1
Actelion
1
Advanz Pharma
1
Alexion
1
Anesiva, Inc.
1
AtriCure, Inc.
1
Total Rows: 15

Clinical Trials at Orlando Heart Center


During the past decade, Orlando Heart Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 8 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years112200000011330000221122Started TrialsCompleted Trails20162017201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
2001-09-01
2004-04-01
Completed
633
Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures
2002-07-01
2005-02-01
Completed
3,000
Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass
2002-01-01
Completed
3,000
Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
2005-06-01
2007-10-01
Completed
235
Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation
2003-08-01
2004-11-01
Completed
356
TAXUS ARRIVE: TAXUS Peri-Approval Registry: A Multi-Center Safety Surveillance Program
2004-02-01
2007-04-01
Completed
2,585
Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)
2008-04-01
2011-07-01
Completed
38
Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
2008-05-01
2009-06-01
Unknown status
600

Rows per page:

1–21 of 21

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Orlando Heart Center" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Biotronik, Inc." with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "United Therapeutics" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Heart Center" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Milton S. Hershey Medical Center" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAbbott Medical Devices: 3Abbott Medical Devices: 3Biotronik, Inc.: 2Biotronik, Inc.: 2Boston Scientific Corporation: 2Boston Scientific Corporation: 2Gilead Sciences: 2Gilead Sciences: 2United Therapeutics: 2United Therapeutics: 2ARYx Therapeutics: 1ARYx Therapeutics: 1Actelion: 1Actelion: 1Advanz Pharma: 1Advanz Pharma: 1Alexion: 1Alexion: 1Anesiva, Inc.: 1Anesiva, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsAstellas Pharma US, Inc.: 1Astellas Pharma US, Inc.: 1Duke Clinical ResearchInstitute: 1Duke Clinical ResearchInstitute: 1Milton S. HersheyMedical Center: 1Milton S. HersheyMedical Center: 1National Heart, Lung,and Blood Institute(NHLBI): 1National Heart, Lung,and Blood Institute(NHLBI): 1Pfizer: 1Pfizer: 1

Clinical Trials Conditions at Orlando Heart Center


According to Clinical.Site data, the most researched conditions in "Orlando Heart Center" are "Heart Failure" (6 trials), "Coronary Artery Disease" (4 trials), "Pulmonary Arterial Hypertension" (4 trials), "Atrial Fibrillation" (3 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Orlando Heart Center" in a lesser frequency.

Clinical Trials Intervention Types at Orlando Heart Center


Most popular intervention types in "Orlando Heart Center" are "Drug" (13 trials), "Device" (9 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "ATI-5923" (1 trials), "Ambrisentan" (1 trials), "Anticoagulation Therapy" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Orlando Heart Center


The vast majority of trials in "Orlando Heart Center" are 21 trials for "All" genders.

Clinical Trials Status at Orlando Heart Center


Currently, there are NaN active trials in "Orlando Heart Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Orlando Heart Center, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Orlando Heart Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Not Applicable: 4Not Applicable: 4Phase 4: 3Phase 4: 3Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 17Completed: 17Terminated: 3Terminated: 3Unknown status: 1Unknown status: 1